Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder Therapy
Clinical trial NCT03824587 · COMPLETED
Trial details
- NCT number
- NCT03824587
- Sponsor
- Ardelyx
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-28
- Primary completion
- 2019-07-17
- Enrollment
- 236
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.